NCSCG GI Symposium Platinum Sponsor

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.

product banner.jpg

NCSCG GI Symposium Platinum Sponsor

Click the Buttons Below to Download:

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC). By harnessing the unique regenerative powers of the liver, our mission is to build a healthier tomorrow for patients and address the liver community’s most pressing needs. Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

For more information contact:

Kevin Weckerle

Territory Business Manager

Kevin.weckerle@interceptpharma.com

Email us for Materials and/or a Visit: info@interceptpharma.com

Hero-Image-Final.jpg

Pfizer Inc.: Breakthroughs that change patient’s lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

EPI Booth_Banner_w_Logo_552x150px JPG.jp

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvieon TwitterFacebookInstagramYouTube and LinkedIn.

For more information contact:

Evan Mavrommatis, Ph.D

Senior Medical Science Liaison

evangelos.mavrommatis@abbvie.com

(415)238-9466

Join our personal meeting room for live chat

Hours: October 17th, 2020 (10am- 1pm)

          October 18th, 2020 (10am - 1pm)

Phone one tap: US: +16699006833,,97984038554# or +12532158782,,97984038554#

Meeting ID: 

979 8403 8554

Passcode:

872738

ABBV-US-00701-E_Banner for events.png

HCV.com is a comprehensive website for healthcare professionals to provide education and resources all in one place. Learn how chronic hepatitis C is diagnosed and treated with comprehensive guides and quickly access go-to references. [ABBV-US-00763-E]

Click the Buttons Below to Download:

Brad Saget, Ph D

Senior Medical Scientist

ABBVIE Virology/Hepatology

415-699-6787 mobile

brad.saget@abbvie.com

HCV.com

Join our personal meeting room for live chat

Hours: October 17th, 2020 (10:30am- 1pm)

          October 18th, 2020 (10:30am - 1pm)

Phone one-tap: 

US: +16699006833,,2285422980# or +12532158782,,2285422980#

 

Meeting URL: 

https://abbvie.zoom.us/j/2285422980

 

Meeting ID: 

228 542 2980

AbbVieLogo_Preferred_RGB.PNG

We are a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

Click the Button Below to Download:

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries. 

Ashley Baxter

Key Account Manager

Northern CA/Nevada

530-519-6737

ashley.baxter@takeda.com

Join our Virtual Exhibit!


Saturday 17 October: 10:30AM - 11:00AM
Sunday 18 October: 10:30AM - 11:00AM

Topic: Bob Buchner's Personal Meeting Room
Join Zoom Meeting
https://zoom.us/j/4716841144?pwd=Y0c2WTkwV2ttK3lVb1kzSHV2Sk11QT09
Meeting ID: 471 684 1144
Passcode: 6YjCuZ

 E: ncscg@pacemedcom.com  T: 714-626-0458  F: 866-735-4373 

 The NCSCG Society is managed by Pace Medical Communications 

  • Wix Facebook page
  • LinkedIn Social Icon